Diet swap study suggests it may never be too late to modify colon cancer risk
the ONA take:
According to a new study published in the journal Nature Communications, African-Americans and Africans who swapped their usual diets for 2 weeks also exchanged their respective colon cancer risks as a result of alterations to their gut flora.
For the study, 20 African-American and 20 rural South African volunteers ate meals typical of the other group for 2 weeks.
Analyses of fecal and colon content samples showed that each group took on the other's rates of turnover of intestinal lining cells, levels of fiber fermentation, and biomarkers of inflammation and bacterial metabolic activity that are linked with colon cancer risk.
The African-American diet, which consists of more animal protein and fat, and less soluble fiber than the typical African diet is thought to increase the risk for colon cancer.
"These findings are really very good news," said principal investigator Stephen O'Keefe, M.D. professor of medicine, Division of Gastroenterology, Hepatology and Nutrition at the Pitt School of Medicine. "In just two weeks, a change in diet from a Westernized composition to a traditional African high-fiber, low-fat diet reduced these biomarkers of cancer risk indicating that it is likely never too late to modify the risk of colon cancer."
African-Americans who swapped their usual diets for 2 weeks also exchanged their respective colon cancer risks.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|